Literature DB >> 27925499

Non-adherence to Psychotropic Medication Among Adolescents - A Systematic Review of the Literature.

Alexander Häge1, Lisa Weymann1, Lucia Bliznak1, Viktoria Märker2, Konstantin Mechler1, Ralf W Dittmann1.   

Abstract

Introduction: Whether patients take their medication as prescribed is of increasing importance in adolescent psychiatry since both the number of efficacious pharmaceutical treatments and the rate of prescriptions of psychotropic compounds are on the rise. Previous research showed high rates of medication nonadherence among both adolescents with medical disorders and adult patients with psychiatric disorders.
Methods: The present review was performed according to PRISMA guidelines and evaluates existing scientific literature concerning adherence to psychotropic medication among adolescents. The goal was to determine rates of nonadherence in this age group as well as the factors associated with it. Therefore, we conducted a comprehensive literature search of PubMed from its inception until 15 September 2015 using the keywords "adherence," "compliance," "adolescent," and "psychotropic medication."
Results: A total of 607 pertinent articles were collected and screened; 15 publications were selected for detailed review. The studies differed, among other things, regarding sample characteristics, medication type, and indications. Furthermore, the definitions of what constitutes nonadherence and the methods used to assess it varied widely. Nonadherence rates ranged from 6 % to 62 % (median 33 %). Conclusions: Nonadherence to psychotropic medication is a clinically relevant problem among adolescents. Because of the methodological heterogeneity across studies and partially contradictory results, no conclusions could be drawn concerning the influence of factors such as psychopathology, medication type, side effects, the effectiveness of treatment, or family-related factors. Well-designed long-term studies of large patient samples and a consensus regarding definitions are therefore warranted. Such research would facilitate the design of tailored strategies to improve adherence in these patients.

Entities:  

Keywords:  Compliance; compliance; nonadherence; operational definition.; partial adherence; psychotropic medication

Mesh:

Substances:

Year:  2016        PMID: 27925499     DOI: 10.1024/1422-4917/a000505

Source DB:  PubMed          Journal:  Z Kinder Jugendpsychiatr Psychother        ISSN: 1422-4917


  6 in total

Review 1.  Dilemmas in the treatment of early-onset first-episode psychosis.

Authors:  Daniel Hayes; Marinos Kyriakopoulos
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-26

2.  Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.

Authors:  Greta A Bushnell; M Alan Brookhart; Bradley N Gaynes; Scott N Compton; Stacie B Dusetzina; Til Stürmer
Journal:  Med Care       Date:  2018-06       Impact factor: 2.983

3.  The Natural Course of Adolescent Depression Treatment in the Primary Care Setting.

Authors:  Allison McCord Stafford; Tamila Garbuz; Dillon J Etter; Zachary W Adams; Leslie A Hulvershorn; Stephen M Downs; Matthew C Aalsma
Journal:  J Pediatr Health Care       Date:  2019-09-21       Impact factor: 1.812

4.  Adolescent attendance at transcultural psychotherapy: a retrospective cohort study.

Authors:  Andrea Diaz Maldonado; Amalini Simon; Caroline Barry; Christine Hassler; Adrien Lenjalley; Carole Giacobi; Marie Rose Moro; Jonathan Lachal
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-03-22       Impact factor: 5.349

Review 5.  Young Minds: Mental Health and Transitional Care in Adolescent and Young Adult Rheumatology.

Authors:  Jason Palman; Janet E McDonagh
Journal:  Open Access Rheumatol       Date:  2020-12-07

6.  Perceptions and Experiences of Adolescents with Mental Disorders and Their Parents about Psychotropic Medications in Turkey: A Qualitative Study.

Authors:  Gül Dikec; Cansın Kardelen; Laura Pilz González; Marjan Mohammadzadeh; Öznur Bilaç; Christiane Stock
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.